Treatable traits in COPD patients

被引：6

作者：

Nucera, Francesco ^{[1
]}

Bianco, Andrea ^{[2
]}

David, Teresa ^{[3
]}

Salvato, Ilaria ^{[1
]}

Adcock, Ian M. ^{[4
]}

Caramori, Gaetano ^{[1
]}

机构：

[1] Univ Messina, Dipartimento Sci Biomed Odontoiatr & Immagini Mor, Pneumol, Messina, Italy

[2] L Vanvitelli Univ Campania, Dept Translat Med Sci, Naples, Italy

[3] G Martino Univ Hosp, Unit Emergency Med, Messina, Italy

[4] Imperial Coll London, Natl Heart & Lung Inst, Sect Airway Dis, London, England

来源：

MINERVA MEDICA | 2022年 / 113卷 / 03期

关键词：

Pulmonary disease; chronic obstructive; Smoking cessation; SARS-CoV-2; Glucocorticoids; Bronchodilator agents; OBSTRUCTIVE PULMONARY-DISEASE; SMOKING-CESSATION; AIRWAY DISEASE; ASTHMA; OUTCOMES; THERAPY; BRONCHIOLITIS; MEDICATIONS; VENTILATION; ADHERENCE;

D O I：

10.23736/S0026-4806.22.08001-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

There is no justification for a therapeutic nihilism in clinical practice because current management (pharmacological and non-pharmacological) of the patients with chronic obstructive pulmonary disease according to treatable traits is effective in decreasing their respiratory symptoms, increasing their exercise tolerance and capacity, improving their quality of life. preventing (and treating) many of their exacerbations and decreasing their mortality.

引用

页码：449 / 459

页数：11

共 50 条

[21] Treatable traits in bronchiectasis
Boaventura, Rita
Sibila, Oriol
Agusti, Alvar
Chalmers, James D.
EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (03)
[22] Phenotypes, treatable traits, GOLD groups and grades - how they predict mortality risk in COPD patients? (data from the Czech Multicenter Research Database of COPD)
Brat, Kristian
Koblizek, Vladimir
Svoboda, Michal
Plutinsky, Marek
Zatloukal, Jaromir
Volakova, Eva
Novotna, Barbora
Popelkova, Patrice
Dvorak, Tomas
Kudela, Ondrej
Kopecky, Michal
Musilova, Pavlina
Kocova, Eva
Vanik, Petr
Heribanova, Lucie
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[23] Addressing treatable traits: a meta-analysis to assess the effect of N-acetylcysteine on respiratory symptoms and exacerbations in pre-COPD and COPD patients
Papi, Alberto
Baraldi, Federico
Alfano, Franco
Bigoni, Tommaso
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[24] Asthma-COPD Overlap in Two Comprehensive Cohorts in Korea: Time to Move to Treatable Traits
Sohn, Kyoung-Hee
JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (30)
[25] From COPD Subtypes to Treatable Traits: Semi-Supervised Disease Axis Discovery in COPDGene
Castaldi, P.
Chen, J.
Cho, M. H.
Estepar, R. San Jose
Washko, G. R.
Hobbs, B. D.
Crapo, J. D.
Lynch, D. A.
Hokanson, J. E.
Dy, J.
Silverman, E. K.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[26] New Treatment Options for COPD: How Do We Decide Phenotypes, Endotypes or Treatable Traits?
Balkissoon, Ron
CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2018, 5 (01): : 72 - 80
[27] The Impact of Number of Treatable Traits to Clinical Remission in patients with Asthma
Yoshida, Chieko
Muramoto, Kei
Anai, Moriyasu
Takaki, Akira
Horio, Yuko
Ideguchi, Hideharu
Tashiro, Takahiro
Tsumura, Shinsuke
Koya, Toshiyuki
Gon, Yasuhiro
Sakagami, Takuro
EUROPEAN RESPIRATORY JOURNAL, 2024, 64
[28] Prevalence of non-pharmacological treatable traits in patients with asthma
Janssen, Steffi
Spruit, Martijn
Antons, Jeanine
Djamin, Remco
Tjalma, Tjitske
'T Veen, Hans In
Simons, Sami
Van Helvoort, Hanneke
Van'T Hul, Alex
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[29] The prevalence of treatable traits in patients with fibrosing interstitial lung disease
Lawler, C.
Fermoyle, C.
Troy, L.
Glenn, L.
Jee, A.
Teoh, A.
Jo, H.
Jackson, D.
Webster, S.
Geis, M.
He, T.
Yuan, T.
Harrison, M.
Khor, Y.
Corte, T.
RESPIROLOGY, 2024, 29 : 218 - 218
[30] Treatable Traits in Systemic Sclerosis
Amati, Francesco
Bongiovanni, Gabriele
Tonutti, Antonio
Motta, Francesca
Stainer, Anna
Mangiameli, Giuseppe
Aliberti, Stefano
Selmi, Carlo
De Santis, Maria
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 65 (02) : 251 - 276

← 1 2 3 4 5 →